A detailed history of Man Group PLC transactions in Absci Corp stock. As of the latest transaction made, Man Group PLC holds 39,990 shares of ABSI stock, worth $114,371. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,990
Holding current value
$114,371
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$2.34 - $3.63 $93,576 - $145,163
39,990 New
39,990 $121,000
Q1 2024

May 15, 2024

BUY
$3.41 - $5.74 $298,647 - $502,709
87,580 Added 86.41%
188,935 $1.07 Million
Q4 2023

Feb 14, 2024

BUY
$1.15 - $4.79 $116,558 - $485,490
101,355 New
101,355 $425,000
Q4 2021

Feb 14, 2022

SELL
$7.88 - $18.03 $91,620 - $209,634
-11,627 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$10.37 - $30.29 $120,571 - $352,181
11,627 New
11,627 $135,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $266M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.